ArticleFrontiers in medicine2026
Risk factors and prognostic impact of continuous renal replacement therapy after heart transplantation: a single-center retrospective study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Heart transplantation (HT) is an effective treatment for end-stage heart disease, but postoperative acute kidney injury (AKI) requiring continuous renal replacement therapy (CRRT) is associated with poor outcomes. Although risk factors for AKI after HT have been well established, studies specifically focusing on CRRT as a clinical endpoint and employing rigorous predictive modeling remain limited. This study aims to identify perioperative risk factors for CRRT after HT and to develop a validated prediction model. Methods: This single-center retrospective study included HT recipients from April 2018 to November 2023. Patients requiring CRRT within 7 days after surgery were compared with those who did not. Candidate predictors were pre-selected based on clinical rationale and previous literature. LASSO regression was used for variable selection to prevent overfitting. A multivariable logistic regression model was then constructed and internally validated using 1,000 bootstrap resamples. Model performance was assessed by discrimination (optimism-corrected AUC), calibration (calibration plot, Hosmer-Lemeshow test), overall fit (Brier score), and clinical utility (decision curve analysis). A time-dependent Cox proportional hazards model was used to evaluate the association between CRRT and postoperative mortality, thereby avoiding immortal time bias. Results: Among 213 recipients, 30 (14.1%) received CRRT. LASSO regression identified nine key predictors: preoperative hemoglobin, preoperative total bilirubin, preoperative ECMO use, cardiopulmonary bypass time, intraoperative blood loss, red blood cell transfusion volume, mechanical ventilation time, VIS score, and lactate peak. Considering the limited number of events (EPV = 10), three core variables were ultimately included in the multivariable model: preoperative hemoglobin (OR 0.963, 95%CI 0.937-0.986, Conclusion: Patients requiring CRRT after HT have a markedly poorer prognosis. The internally validated multifactorial model, incorporating preoperative hemoglobin, VIS score, and lactate peak, provides robust predictive value for CRRT and may facilitate early risk stratification. The significant association between CRRT and mortality underscores the critical need for targeted perioperative interventions in high-risk patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.